(ITB) iShares U.S. Home - Ratings and Ratios
Homebuilder, Supplier, Retailer, ETF
Dividends
| Dividend Yield | 1.70% |
| Yield on Cost 5y | 2.89% |
| Yield CAGR 5y | 51.28% |
| Payout Consistency | 91.8% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 28.0% |
| Value at Risk 5%th | 43.8% |
| Relative Tail Risk | -4.81% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.04 |
| Alpha | -12.62 |
| CAGR/Max DD | 0.56 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.395 |
| Beta | 0.730 |
| Beta Downside | 0.422 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.35% |
| Mean DD | 11.03% |
| Median DD | 8.46% |
Description: ITB iShares U.S. Home January 12, 2026
The iShares U.S. Home Construction ETF (BATS: ITB) tracks an index that captures the performance of U.S. home-building equities. The fund is required to hold at least 80 % of its net assets in the index’s constituent stocks and may allocate up to the remaining 20 % to futures, options, swaps, cash, or cash equivalents; it is classified as a non-diversified, consumer-cyclical ETF.
Key drivers to watch: (1) **Housing starts** – the U.S. Census Bureau reported 1.58 million new single-family starts in 2024 Q3, a 4 % YoY increase, which directly fuels revenue for ITB constituents. (2) **Builder confidence** – the NAHB/Wells Fargo Housing Market Index rose to 57 in October 2024, its highest level since 2022, suggesting stronger demand outlook. (3) **Mortgage rates** – the 30-year Treasury yield, a proxy for mortgage rates, has hovered around 4.8 % in recent weeks; lower rates historically correlate with higher home-builder margins, but any upward pressure could compress earnings.
Given the sensitivity of home-builder earnings to interest-rate cycles and inventory constraints, monitoring these macro variables can help assess ITB’s upside potential. For a deeper, data-driven breakdown of ITB’s exposure and risk metrics, you might find ValueRay’s analytics platform useful.
What is the price of ITB shares?
Over the past week, the price has changed by +0.03%, over one month by +8.04%, over three months by +4.06% and over the past year by +0.52%.
Is ITB a buy, sell or hold?
What are the forecasts/targets for the ITB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 123 | 14% |
ITB Fundamental Data Overview January 18, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.14b USD (3.14b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.14b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.14b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.60% (E(3.14b)/V(3.14b) * Re(8.60%) + (debt-free company))
Discount Rate = 8.60% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for ITB ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle